April 9 (Reuters) - C4 Therapeutics said on Thursday it has entered into a deal focused on research and development of a type ...
Agreement Focused on Developing DACs With Payloads For Two Oncology Targets, With an Option for a Third TargetC4T to Develop Degraders With ...
Roche has joined its Big Pharma peers in the emerging degrader-antibody conjugate (DAC) space, paying C4 Therapeutics $20 ...
C4 Therapeutics will receive $20m upfront in addition to milestone payments, with a potential $1bn in additional milestones.
C4 Therapeutics Inc. CCCC shares rose in Thursday’s session after climbing as high as $3.66 in premarket trading. The company ...
GlobalData on MSN
C4 Therapeutics begins dosing in Phase Ib trial for multiple myeloma
The Phase Ib trial will enrol around 54 patients to study cemsidomide with elranatamab and dexamethasone.
Financially, the agreement includes a $20 million upfront payment to C4 Therapeutics, with the potential for additional ...
Screens overtaking cars is a controversial trend among enthusiasts, but it wasn’t always. I’ll risk my neck here and say I can’t imagine most people could watch the video below of a 1987 C4 Chevy ...
The first hard pull in the C8 ZR1 is genuinely shocking. Even without using a low gear, the thrust is violent. A proper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results